Toggle Offcanvas
...
 
Dutasteride Tenders

Dutasteride Tenders

View Dutasteride tenders, RFPs and contracts. Bid on readily available Dutasteride tenders with the best and most comprehensive tendering platform, since 2002.
Dutasteride is a medication used to treat benign prostatic hyperplasia BPH . It works by reducing the size of the prostate gland, improving urine flow, and relieving symptoms associated with an enlarged prostate.

Bidding for Dutasteride tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dutasteride.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dutasteride market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dutasteride tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

40 Live Notices for Dutasteride Tenders

Showing 1 to 20

Supply of Medicine and Medical / Surgical equipments : Dutasteride Capsule 0.5mg\nDutasteride capsule 0.5 mg\nEach tablet to contain 0.5mg of Dutasteride\nNote: 01.The shelf life of the product should be\nminimum of 24 months etc .
country Sri Lanka
posting date31 May 2025
deadline12 Jun 2025
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamsulosine And Dutasteride, Atc G04Ca52
country Germany
posting date11 Apr 2025
deadline31 Mar 2027
Medicines With The Active Ingredient Combination Tamsulosin And Dutastasteride (Atc: G04Ca52)
country Germany
posting date10 Apr 2025
deadline30 Nov 2025
Medicines With The Active Ingredient Combination Tamsulosin And Dutastasteride (Atc: G04Ca52)
country Germany
posting date10 Apr 2025
deadline30 Nov 2025
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open-House Model To The Active Ingredient Tamsulosin/Dutasteride (Atc Code According To Who: G04Ca52)
country Germany
posting date26 Mar 2025
deadline31 May 2027

Share Share this page